Apple Cuts Over 200 Siri, Vision Pro Jobs in AI Shift 
KPMG Australia Cuts 5% of Workforce Amid Scandal 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Alibaba Raises $10.2 Billion to Expand AI Infrastructure 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets 
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p 
Trump Buys SpaceX Shares After Record IPO 
Add as a preferred source on Google
DUBLIN, IRELAND, May 01, 2018 -- Horizon Pharma plc (NASDAQ:HZNP), today announced that the company will participate in the following conference in May:
UBS Global Healthcare Conference
- Date: May 22, 2018
- Presentation Time: 9:30 a.m. ET
- Location: New York
The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for the event.
About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.
| Contacts: | |
| Investors: Tina Ventura Senior Vice President, Investor Relations [email protected] | U.S. Media: Geoff Curtis Senior Vice President, Corporate Affairs & Chief Communications Officer [email protected] |
| Ruth Venning Executive Director, Investor Relations [email protected] | Ireland Media: Ray Gordon Gordon MRM [email protected] |
